Neonatal respiratory distress syndrome (NRDS) is a condition primarily affecting premature infants, caused by insufficient surfactant production in the lungs, leading to alveolar collapse and impaired gas exchange. Prompt treatment with surfactant replacement therapy and supportive care can significantly improve outcomes and reduce the risk of complications.